Skoneczna, I.

patient treatment cancer study cisplatin survival chemotherapy oncology m-cavi toxicity response group phase trial cycle disease marker grade hd-ct death oncology information downloaded hd-vip gemcitabine analysis m-cavi arm society difference etoposide american society erasmus universiteit rotterdam bajorin gc arm result bajorin risk groups high-dose table randomized oncol decline signi erasmu reason grade 3 therapy erasmus mc marker decline volume 22 | /carboplatin firmed uncon firmed medische bibliotheek urothelial number high-dose chemotherapy firmed progression downloaded methotrexate factor bladder cisplatin-based chemotherapy month bajorin risk factors ifosfamide bladder cancer information 0.0 metastase 5 | tumor santi hd-ct arm carboplatin cisplatin therapy ficant performance status author carcinoma classi fied bep arm fit patients